NIOME subnet 55
NIOME presents Subnet 55 as a decentralized genomic-data network that replaces real human genomes with synthetic profiles. The project is aimed at enabling biomedical and pharmaceutical research while reducing exposure to real patient data. Its official materials emphasize synthetic genomic data, drug-response prediction, and privacy-safe workflows for precision medicine research.
About NIOME subnet 55
NIOME is a Genomes.io subnet for privacy-safe synthetic genomic data and genomic-intelligence workflows.
Genomic research is constrained by privacy laws, consent limits, and data-access bottlenecks, even when larger datasets could improve drug-response and precision-medicine models.
Pharmaceutical researchers, precision-medicine teams, bioinformatics groups, privacy-focused data platforms, miners, and validators.
Team and ownership
NIOME is developed by Genomes.io. Aldo de Pape is Genomes.io CEO and founder/chairman of TeachPitch.
- Aldo de Pape, CEO, Genomes.io: CEO at Genomes.io and founder/chairman of TeachPitch.
Public partnerships
- Bittensor: Genomes.io announced a partnership with Bittensor to build a subnet dedicated to synthetic genomic data for AI-driven genomics.
- Yuma: Yuma publicly highlighted NIOME as an accelerated subnet, positioning it as part of its Bittensor subnet-development program.
Key pages:
learn about Bittensor,
Bittensor glossary,
Bittensor FAQ,
Bittensor subnet screener,
portfolio tracker,
subnet baskets,
Neuralteq validator,
and fees.